K. Haider

099 Erectile function improves in hypogonadal men with type 2 diabetes under long-term testosterone therapy: real-world evidence from a urological registry study

097 In obese hypogonadal men, long-term testosterone therapy improves erectile function, quality of life and body weight – real-life evidence from a registry study

090 Reduction of major adverse cardiovascular events (MACE) and improvement of erectile function in hypogonadal men receiving testosterone therapy – real-life evidence from a registry study

131 Prostate Cancer Incidence and Severity in Testosterone-treated vs. Untreated Hypogonadal Men: Real-life Experience from more than 5500 Patients Years

127 Testosterone Therapy leads to Sustained Weight Loss, Improved Erectile Function and Reduction of MACE in Hypogonadal Men in a 10-year Real-life Registry

001 Urinary and Sexual Function in 411 Obese Hypogonadal Men with and without Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office

105 Improvement of Type 2 Diabetes (T2DM) in Hypogonadal Men receiving Long-term Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office

005 Erectile Function in 164 Matched Hypogonadal Men: Results of Long Term Treatment With Testosterone Undecanoate Injections (TU) in Comparison With Control Group

016 Long-term Testosterone Treatment Improves Urinary and Sexual Function in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study

130 Long-term Testosterone Treatment Improves Glycemic Control in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study